StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 16, 2026, 04:37 PM

Organogenesis Stockholders Elect 9 Directors, Approve Exec Comp, Auditor

AI Summary

Organogenesis Holdings Inc. held its 2026 Annual Meeting of Stockholders on June 15, 2026, where three proposals were approved. Stockholders re-elected Garrett Lustig and elected nine other directors to the board. Additionally, the compensation paid to named executive officers was approved on an advisory basis, and the appointment of RSM US LLP as the independent registered public accounting firm for fiscal year 2026 was ratified.

Key Highlights

  • Organogenesis stockholders re-elected Garrett Lustig to the board of directors.
  • Nine directors were elected to the board, including Robert Ades and Michael J. Driscoll.
  • 129,564,421 shares were present or represented at the Annual Meeting.
  • Advisory vote on executive compensation was approved with 72,516,011 votes For.
  • Appointment of RSM US LLP as auditor for 2026 was ratified with 128,421,160 votes For.
  • Robert Ades received 85,064,304 votes For director election.
  • Glenn H. Nussdorf received 61,049,018 votes For director election.